UPDATE: US pauses rollout of J&J’s COVID-19 vaccine amid reports of rare blood clots
An advisory committee to the CDC recommended extending the pause in the US to review additional data
UPDATE: Johnson & Johnson’s (J&J) COVID-19 vaccine will remain on hold after a health advisory panel in the US failed to reach a decision on the nationwide pause during a meeting yesterday.
The Centers for Disease Control & Prevention (CDC) convened a meeting of the Advisory Committee on Immunization Practices (ACIP) on Wednesday to review reported cases of blood clots in people who had received J&J s vaccine and to assess their ‘potential significance’.
Justice signs syringe exchange bill, despite health leaders push for a veto wvmetronews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wvmetronews.com Daily Mail and Mail on Sunday newspapers.
The Centers for Disease Control & Prevention confirmed to the Virginia Department of Health it is examining the March death of a Virginia woman as part of its investigation into possible adverse side effects from the Johnson & Johnson COVID-19 vaccine. Six cases had been reported across the country but this is the first word that a death is linked to the vaccine. Virginia along with other states paused distribution of the J&J vaccine and will only use Pfizer and Moderna.
Apr. 15, 2021 at